Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v3-FR
Language English French
Date Updated 2020-07-17 2020-05-29
Drug Identification Number 02240770 02240770
Brand name MICARDIS 80MG TAB MICARDIS 80MG TAB
Common or Proper name Micardis 80MG Micardis 80MG
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients TELMISARTAN TELMISARTAN
Strength(s) 80MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 28s 28s
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-06-08 2020-06-08
Actual start date 2020-06-01
Estimated end date 2020-07-24 2020-07-08
Actual end date 2020-07-17
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments